CS logo
small CS logo
ICO Girona

Girona, Spain
Centro de tratamiento del cáncer, Gerona

About ICO Girona


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Fundación GECP
8
PETHEMA Foundation
6
Spanish Breast Cancer Research Group
5
Grupo Español de Investigación en Cáncer de Ovario
4
Janssen Research & Development, LLC
3
MedSIR
3
Pfizer
3
Gilead Sciences
2
Hoffmann-La Roche
2
AGO Research GmbH
1
Ability Pharmaceuticals SL
1
Total Rows: 35

Clinical Trials at ICO Girona


During the past decade, ICO Girona conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 13 clinical trials were completed, i.e. on average, 26% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 9 clinical trials were completed. i.e. 36% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years3333666677111199550000000044222244Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
2004-02-01
2019-04-04
Completed
1,384
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
2005-03-01
2009-12-01
Completed
260
LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
2006-10-01
2009-11-01
Completed
50
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
1996-06-01
2007-12-01
Completed
374
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
2007-11-06
2014-07-24
Completed
380
Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
2009-11-01
2014-05-01
Terminated
115
Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone
2011-02-01
2016-05-01
Completed
250
Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer
2010-11-08
2015-02-13
Completed
78

Rows per page:

1–62 of 62

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "ICO Girona" #1 sponsor was "Fundación GECP" with 8 trials, followed by "PETHEMA Foundation" with 6 trials sponsored, "Spanish Breast Cancer Research Group" with 5 trials sponsored, "Grupo Español de Investigación en Cáncer de Ovario" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 35 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ICO Girona" #1 collaborator was "Hoffmann-La Roche" with 6 trials as a collaborator, "Apices Soluciones S.L." with 3 trials as a collaborator, "GlaxoSmithKline" with 3 trials as a collaborator, "AGO Study Group" with 2 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 53 trials.
Created with Highcharts 11.1.0Top Leading SponsorsFundación GECP: 8Fundación GECP: 8PETHEMA Foundation: 6PETHEMA Foundation: 6Spanish Breast CancerResearch Group: 5Spanish Breast CancerResearch Group: 5Grupo Español deInvestigación en Cáncerde Ovario: 4Grupo Español deInvestigación en Cáncerde Ovario: 4Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3MedSIR: 3MedSIR: 3Pfizer: 3Pfizer: 3Gilead Sciences: 2Gilead Sciences: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2AGO Research GmbH: 1AGO Research GmbH: 1

Created with Highcharts 11.1.0Top CollaboratorsHoffmann-La Roche: 6Hoffmann-La Roche: 6Apices Soluciones S.L.: 3Apices Soluciones S.L.: 3GlaxoSmithKline: 3GlaxoSmithKline: 3AGO Study Group: 2AGO Study Group: 2ARCAGY/ GINECO GROUP: 2ARCAGY/ GINECO GROUP: 2Celgene: 2Celgene: 2German Breast Group: 2German Breast Group: 2Ipsen: 2Ipsen: 2Janssen-Cilag Ltd.: 2Janssen-Cilag Ltd.: 2MaNGO: 2MaNGO: 2

Clinical Trials Conditions at ICO Girona


According to Clinical.Site data, the most researched conditions in "ICO Girona" are "Breast Cancer" (6 trials), "Multiple Myeloma" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Oral Mucositis" (3 trials) and "Early Breast Cancer" (2 trials). Many other conditions were trialed in "ICO Girona" in a lesser frequency.

Clinical Trials Intervention Types at ICO Girona


Most popular intervention types in "ICO Girona" are "Drug" (55 trials), "Other" (7 trials), "Radiation" (4 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (9 trials), "Atezolizumab" (7 trials), "Bevacizumab" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

Clinical Trials Genders at ICO Girona


The vast majority of trials in "ICO Girona" are 42 trials for "All" genders, 16 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at ICO Girona


Currently, there are NaN active trials in "ICO Girona". undefined are not yet recruiting, 16 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in ICO Girona, undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in ICO Girona, 5 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 26Phase 2: 26Phase 3: 25Phase 3: 25Phase 1: 5Phase 1: 5Not Applicable: 2Not Applicable: 2Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 19Active, not recruiting: 19Completed: 19Completed: 19Recruiting: 16Recruiting: 16Terminated: 7Terminated: 7Unknown status: 1Unknown status: 1